Venture Fund Member Profile
|
 |
 |
We are an early-stage venture capital firm with $560 million under management. Our goal is to find talented entrepreneurs and then partner with them to build exceptional and valuable companies. We focus on providing guidance and perspective in a complimentary way to the entrepreneurs we invest in and help them build connections to soar to the next level.
Founded in 2001 as Boston-based IDG Ventures Atlantic, we re-named the firm Flybridge Capital Partners in 2008 to better reflect our position as a firm with a broad, blue-chip investor base and diverse sector focus.
We invest in seed and early-stage, capital efficient companies in the consumer, healthcare and information technology markets. We invest in privately-held US start-up companies seeking capital to fuel growth and expand operations. We are typically the first institutional investor in the company, and serve as the lead or co-lead
 |
Matthew Witheiler
Senior Associate
Flybridge Capital Partners |
Matt is a Senior Associate at Flybridge Capital Partners whose investment interests and experience broadly cover companies and technologies across the information technology sector including digital media, semiconductors and enterprise infrastructure.
Matt joined the firm in July 2008 after completing his MBA at Harvard School of Business (HBS). Prior to HBS, Matt spent seven years in various roles in the high technology industry. Most recently, Matthew was a Summer Associate at Jefferies Broadview in technology investment banking where he advised on sale, IPO and debt strategies of various companies in the technology industry. Prior to that, Matthew spent three years at ATI Technologies, a $4B 3D-graphics silicon provider. At ATI, Matt focused on the integration of 3D graphics and digital video and was responsible for the TV on the PC integrated circuit product line. He researched, led development and launched the company’s flagship multimedia processor. Before joining ATI, Matt served for four years as co-owner and Senior Hardware Editor of the successful hardware review website, AnandTech.com, where he helped build one of the world’s largest hardware review sites.
Matthew holds a BS in Public Policy Studies from Duke University and an MBA from the Harvard Business School.
Outside of the office, Matthew is an avid mountain biker, skier and SCUBA diver. At HBS, Matthew sat as the Section F Treasurer and Co-Chair of Cyberposium 2007.
Representative Investments
 |
PolyRemedy, Inc. manufactures robotic systems for the fabrication of nano-material based wound dressings at the point-of-care, allowing wound care clinicians to easily and cost-effectively deliver customized wound care on-demand for each patient’s unique wound. |
 |
Magen BioSciences is focused on improving the health and appearance of human skin. Magen pursues a science-driven approach to identify and develop novel therapeutics to treat a number of large, poorly served dermatological disorders. The company has assembled an outstanding science, investor and management team. The team includes co-founders of Idexx, Immunex, Alnylam, Momenta, Vertex, Biogen and Genzyme. The company is headquartered in Massachusetts. |
 |
Brontes Technologies Acquired by 3M Brontes is changing the way dentists treat their patients by enabling practitioners to perform ImpressionFreeTM dentistry. Brontes’ 3D intraoral imaging technology can quickly and painlessly scan both arches of the mouth, thereby replacing the antiquated dental impression process. Over 50 million dental impressions are performed in the U.S. each year for the production of almost all dental prosthetics and appliances, including crowns, bridges, implants, braces, aligners and retainers. The average dentist takes several impressions each day in spite of the costly, time consuming, inconsistent, and unpleasant process. Digital tools for production have been available to the dental industry for many years, but all of these tools start with the same problematic physical input – the dental impression. Brontes enables a long overdue digital revolution by taking 3D digital data directly from the patient’s mouth and removing the barriers to digital production. Brontes Technologies, Inc. was founded in 2003 based on the research of Dr. János Rohály, Professor Douglas Hart and two graduate students from the Department of Mechanical Engineering at the Massachusetts Institute of Technology, Eric Paley and Micah Rosenbloom. In October 2006 Brontes Technologies was acquired by 3M |
 |
Infobright is taking a radical new approach to data warehousing. Infobright’s Brighthouse analytic data warehouse software is designed to answer some of the most complex, detailed questions involving massive amounts of information, and answer those questions today, not next week. By fundamentally reinventing data warehouse architecture, Brighthouse "works smarter, not harder." Brighthouse achieves breakthrough performance, while eliminating the need for indices, data partitions, and other physical data structures, as well as the need to deploy large hardware systems. By delivering the most powerful and usable analytic data warehouse, Infobright is enabling companies to bring a whole new level of information intelligence to business operations.
|
Matthew participated in the FundingPost event: Perfect Venture Conference V
on November 12, 2009 in NY, Sponsored by Duane Morris, Shelowitz & Associates, TriNet
To list your Company on our website and make your profile available to Matthew and 7,500+ other VCs and Angel Investors, Click Here.
============================================
About FundingPost
For over Twelve Years FundingPost has worked with thousands
of Angel and Venture Capital Investors. We believe that it is
important to reach investors in every medium possible -
both online and offline. We have been directly responsible for
tons of success stories and Millions and Millions of dollars raised.
We look forward to introducing your company to the leading Venture and Angel Investors nationwide.
============================================
|
| Venture Fund Member Profile |
|
Bookmark to del.icio.us
Tweet this Profile
